Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong
· Delayed Price · Currency is HKD
66.40
+5.45 (8.94%)
Mar 10, 2026, 3:55 PM HKT
Nanjing Leads Biolabs Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | - | -301.22 | -362.25 |
| Depreciation & Amortization | - | 26.04 | 23.91 |
| Loss (Gain) From Sale of Investments | - | -1.72 | -6.24 |
| Stock-Based Compensation | - | 41.94 | 17.84 |
| Other Operating Activities | - | 45.81 | 115.96 |
| Change in Inventory | - | - | 2.04 |
| Change in Accounts Payable | - | 25.05 | -1.55 |
| Change in Unearned Revenue | - | 84.22 | - |
| Change in Other Net Operating Assets | - | -38.94 | 17.61 |
| Operating Cash Flow | - | -118.82 | -192.69 |
| Capital Expenditures | - | -2.98 | -11.73 |
| Investment in Securities | - | -64.33 | 147.22 |
| Investing Cash Flow | - | -67.3 | 135.49 |
| Long-Term Debt Issued | - | 274.98 | 61 |
| Long-Term Debt Repaid | - | -86.34 | -4.64 |
| Net Debt Issued (Repaid) | - | 188.64 | 56.37 |
| Issuance of Common Stock | - | 130.51 | - |
| Other Financing Activities | - | -10.12 | -6.87 |
| Financing Cash Flow | - | 309.02 | 49.49 |
| Foreign Exchange Rate Adjustments | - | 2.12 | 2.7 |
| Net Cash Flow | - | 125.02 | -5 |
| Free Cash Flow | - | -121.79 | -204.41 |
| Free Cash Flow Margin | - | - | -2305.84% |
| Free Cash Flow Per Share | - | -0.81 | -1.41 |
| Cash Interest Paid | - | 5.19 | 6.87 |
| Levered Free Cash Flow | - | -1,339 | - |
| Unlevered Free Cash Flow | - | -1,336 | - |
| Change in Working Capital | - | 70.33 | 18.09 |
Source: S&P Capital IQ. Standard template.
Financial Sources.